Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Bronchial Neoplasms; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Lung Diseases; Lung Neoplasms; Neoplasms; Neoplasms by Site; Respiratory Tract Diseases; Respiratory Tract Neoplasms; Thoracic Neoplasms Phase 3 ClinicalTrials
Hodgkin Disease; Lymphoma Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Hepatocellular Phase 2 ClinicalTrials
Neoplasms Phase 1/Phase 2 ClinicalTrials
Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma; Neoplasms, Squamous Cell Phase 2 ClinicalTrials
Uterine Cervical Neoplasms Phase 2 ClinicalTrials
Stomach Neoplasms Phase 2 ClinicalTrials
Esophageal Neoplasms Phase 3 ClinicalTrials
Carcinoma, Non-Small-Cell Lung Phase 2 ClinicalTrials
Breast Neoplasms Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 1 ClinicalTrials
Breast Neoplasms; Gastrointestinal Neoplasms Phase 1 ClinicalTrials
Nasopharyngeal Carcinoma Phase 1 ClinicalTrials
Lung Neoplasms Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung Phase 2 ClinicalTrials
Neoplasms Phase 1 ClinicalTrials
Lymphoma; Lymphoma, Extranodal NK-T-Cell; Lymphoma, T-Cell Phase 2 ClinicalTrials
Digestive System Diseases; Digestive System Neoplasms; Esophageal Diseases; Esophageal Neoplasms; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Neoplasms Phase 2 ClinicalTrials
Bronchial Neoplasms; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Lung Diseases; Lung Neoplasms; Neoplasms; Respiratory Tract Diseases; Respiratory Tract Neoplasms Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma Phase 2 ClinicalTrials
Hodgkin Disease; Lymphoma Phase 2 ClinicalTrials
Esophageal Neoplasms Phase 3 ClinicalTrials
Stomach Neoplasms Phase 3 ClinicalTrials
Lung Neoplasms; Small Cell Lung Carcinoma Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Renal Cell Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Hepatocellular Phase 2 ClinicalTrials
Melanoma Phase 1 ClinicalTrials
Carcinoma; Carcinoma, Hepatocellular; Stomach Neoplasms Phase 1/Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Endometrial Neoplasms; Ovarian Neoplasms; Uterine Cervical Neoplasms Phase 2 ClinicalTrials
Carcinoma; Liver Neoplasms Phase 2 ClinicalTrials
Lymphoma; Lymphoma, B-Cell Phase 1/Phase 2 ClinicalTrials
Colorectal Neoplasms Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Hepatocellular Phase 3 ClinicalTrials
Carcinoma; Nasopharyngeal Carcinoma Phase 2 ClinicalTrials
Lung Neoplasms Phase 3 ClinicalTrials
Osteosarcoma Phase 2 ClinicalTrials
CONTENTS